Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV Evaluation of Tri Fluvac Influenza Vaccine Effectiveness in Thai Population
TCTR20240909002Phase 4Completed
- Sponsor
- Government Pharmaceutical Organization
- Start
- Sep 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Tri Fluvac in influenza, sponsored by Government Pharmaceutical Organization. Started Sep 2024; status: completed.
02
Drugs
Tri Fluvac
03
Conditions
influenza
Beyond the preview
Go deeper on TCTR20240909002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240909002.